National Drug Code (NDC) Database
Gehring-Montgomery, Inc
-
NDC:
63163-002
-
Nonproprietary Name:
PROPYLENE GLYCOL
-
Dosage Form:
LIQUID
-
Product Type:
BULK INGREDIENT
-
Strength:
100 kg/100kg
-
Substance:
PROPYLENE GLYCOL
-
Start Marketing Date:
1984-01-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Gemini PharmChem Mannheim GmbH
-
NDC:
77391-005
-
Nonproprietary Name:
Valrubicin
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
VALRUBICIN
-
Start Marketing Date:
2021-08-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Genentech, Inc.
-
NDC:
50242-931
-
Nonproprietary Name:
somatropin
-
Dosage Form:
SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
5 g/2L
-
Substance:
SOMATROPIN
-
Start Marketing Date:
1995-12-29
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Genentech, Inc. (SSF)
-
NDC:
50242-160
-
Nonproprietary Name:
Bevacizumab
-
Dosage Form:
LIQUID
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
25 g/L
-
Substance:
BEVACIZUMAB
-
Start Marketing Date:
2004-02-26
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
GenIbet Biopharmaceuticals
-
NDC:
83461-400
-
Nonproprietary Name:
Fecal Microbiota Spores, Live-brpk
-
Dosage Form:
CAPSULE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
30000000 [CFU]/1
-
Substance:
DONOR HUMAN STOOL SPORES (ETHANOL TREATED)
-
Start Marketing Date:
2023-04-26
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
GENTEC S.A.
-
NDC:
81997-001
-
Nonproprietary Name:
Latanoprost
-
Dosage Form:
OIL
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
LATANOPROST
-
Start Marketing Date:
2021-07-12
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
GenTrac Inc.
-
NDC:
52766-0100
-
Nonproprietary Name:
thrombin
-
Dosage Form:
LIQUID
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
THROMBIN
-
Start Marketing Date:
1986-02-03
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Genzyme Corporation
-
NDC:
58468-5151
-
Nonproprietary Name:
Dupilumab
-
Dosage Form:
SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
175 mg/mL
-
Substance:
DUPILUMAB
-
Start Marketing Date:
2020-08-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Genzyme Ireland Limited
-
NDC:
83246-065
-
Nonproprietary Name:
efanesoctocog alfa
-
Dosage Form:
POWDER, FOR SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
4000 [iU]/3mL
-
Substance:
EFANESOCTOCOG ALFA
-
Start Marketing Date:
2024-08-07
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
-
NDC:
62049-185
-
Nonproprietary Name:
FLUOROURACIL
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
FLUOROURACIL
-
Start Marketing Date:
2019-05-07
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.